BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biologics

Alphamab Oncology and CSPC’s Anti-HER2 ADC JSKN003 Secures Breakthrough Therapy Designation in China

Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that anti-HER2 biparatopic...

March 19, 2025 | News

SOPHiA GENETICS Surpasses Two Million Genomic Profiles Analyzed on AI-Powered Platform

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, has reached a historic milestone: more than two million...

March 19, 2025 | News

Chance Pharmaceuticals Secures New Funding to Advance Phase III Trials for CXG87 and Expand Inhalation Therapy Pipeline

Chance Pharmaceuticals ("Chance Pharma"), a clinical-stage biotechnology company dedicated to the research and development of innovative inhalation therapi...

March 18, 2025 | News

Rona Therapeutics Secures FDA IND Clearance for RN0361, Advancing RNAi Therapy for Severe Hypertriglyceridemia

Rona Therapeutics Inc., a global leader in RNA-targeted therapeutics, announced the clearance of an Investigational New Drug (IND) by the U.S. Food and Dru...

March 18, 2025 | News

South Korea’s Galux Inc. Achieves Breakthrough in AI-Driven Antibody Design for Multiple Therapeutic Targets

Pioneering AI technology successfully designs antibodies de novo for six therapeutic targets, including one without an experimentally resolved structure ...

March 18, 2025 | News

Innovent’s SYCUME® Becomes China’s First IGF-1R Antibody Approved for Thyroid Eye Disease

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...

March 17, 2025 | News

Celonic Integrates Merck’s Breez™ Micro-Bioreactor to Advance mAb Development

Celonic Group, a Swiss-Based Quality contract development and manufacturing organization (CDMO), has announced that it is integrating Merck’s Breez&t...

March 13, 2025 | News

Pierre Fabre and RedRidge Bio Partner to Develop Biparatopic Antibody Drug Candidates

Pierre Fabre Laboratories and RedRidge Bio announced an exclusive R&D collaboration and license agreement to identify and develop biparatopic...

March 13, 2025 | News

Telix Pharmaceuticals Develops High-Yield Lead-212 Generator to Advance Targeted Alpha Therapy

Telix Pharmaceuticals Limited announces that it has developed and validated a breakthrough generator technology for the production of lead-212 (212Pb...

March 13, 2025 | News

GC Cell Begins Phase 1 Clinical Trial for CD5 CAR-NK Therapy GCC2005 in T-Cell Lymphomas

GC Cell , under the leadership of CEO Sungyong Won, announced today the initiation of its domestic Phase 1 clinical trial for GCC2005 (AB‑205), a no...

March 13, 2025 | News

Navigating Biologics Development: Strategies for Regulatory Success, CMC Challenges, and Tech Transfer

Click here to Register Now! As the biologics field rapidly evolves, mastering regulatory pathways, process development, and tech transfer is essential for...

March 12, 2025 | News

WuXi XDC and AbTis Partner to Advance Site-Selective ADC Conjugation

WuXi XDC Cayman Inc. ("WuXi XDC" or the "Company", stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organiza...

March 12, 2025 | News

Sichuan Kelun-Biotech’s TROP2 ADC Sacituzumab Tirumotecan Secures NMPA Approval for EGFR-Mutant NSCLC

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company's trophoblast cell-surface antigen 2 (TROP...

March 11, 2025 | News

GenAssist Gains FDA IND Clearance for First-in-Class Base Editing Therapy for Duchenne Muscular Dystrophy

GenAssist Ltd (GenAssist), a pioneering gene-editing biotechnology company specializing in genome medicines, is thrilled to announce that it has received&n...

March 07, 2025 | News

Stay Connected